本文に飛ぶ

年 〜
年

検索結果 17 件

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice 27 11

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice 27 11
デジタル博士論文障害者向け資料あり
Rahadian, Arief, Fukuda, Daiju, Salim, Hotimah Masdan, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Sata, MasatakaJapan Atherosclerosis Society2020-11-01Journal of Atherosclerosis and Thrombosis
国立国会図書館
  • 件名SGLT2 inhibitor Canagliflozin Atherosclerosis...

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in an animal model of obese type 2 diabetes

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in an animal model of obese type 2 diabetes
デジタル博士論文障害者向け資料あり
原, 健人2023-07-01
国立国会図書館
  • 件名Fat oxidation Metabolic inflexibility Obesity SGLT2 inhibitor Type 2 diabetes mellitus

Effects of a Novel Selective PPARα Modulator, Statin, Sodium-Glucose Cotransporter 2 Inhibitor, and Combinatorial Therapy on the Liver and Vasculature of Medaka Nonalcoholic Steatohepatitis Model

Effects of a Novel Selective PPARα Modulator, Statin, Sodium-Glucose Cotransporter 2 Inhibitor, and Combinatorial Therapy on the Liver and Vasculature of Medaka Nonalcoholic Steatohepatitis Model
デジタル博士論文障害者向け資料あり
Kimura, Atsushi2022-03-23
国立国会図書館
  • 件名NASH fli::GFP transgenic medaka SPPARMα statin SGLT2 inhibitor

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 Inhibitor use

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 Inhibitor use
デジタル博士論文障害者向け資料あり
後藤, 由佳2021-07-01
国立国会図書館
  • 件名SGLT2 inhibitor diabetes mellitus glucose flu...

Liver autophagy-induced valine and leucine in plasma reflect the metabolic effect of sodium glucose co-transporter 2 inhibitor dapagliflozin

Liver autophagy-induced valine and leucine in plasma reflect the metabolic effect of sodium glucose co-transporter 2 inhibitor dapagliflozin
デジタル博士論文障害者向け資料あり
Furuya, Futoshi2023-05-23
インターネットで読める国立国会図書館全国の図書館

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. 32 3

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. 32 3
デジタル博士論文障害者向け資料あり
富田, 一聖, TOMITA, IsseiElsevier B.V.2020Cell metabolism
国立国会図書館
  • 件名...is ketone body SGLT2 inhibitor lipolysis ketolysis mTORC1 nu...
  • 一般注記pdf SGLT2 inhibitors offer strong renoprotection ...

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
デジタル博士論文
吉本, 卓生2017-09-27
国立国会図書館
  • 件名SGLT2 inhibitor blood pressure type 2 diabete...
  • 一般注記...2 diabetes. An SGLT2 inhibitor (canagliflozin......Treatment with SGLT2 inhibitors significantly......inistration of SGLT2 inhibitors. However, the......treatment with SGLT2 inhibitors does not activate the intrar...

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). 10

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). 10
デジタル博士論文障害者向け資料あり
Nakajima, Hiroki, Okada, Sadanori, Mohri, Takako, Kanda, Eiichiro, Inaba, Naoyuki, Hirasawa, Yoko, Seino, Hiroaki, Kuroda, Hisamoto, Hiyoshi, Toru, Niiya, Tetsuji, Ishii, HitoshiBioMed Central2018-03-01Diabetology and metabolic syndrome
国立国会図書館
  • 件名...s 2 inhibitors SGLT2 inhibitors Dapagliflozin Treatment sati...
  • 一般注記...agliflozin, an SGLT2 inhibitor, improves treatment satisfact...

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
デジタル博士論文
ラハディアン, アリエフ, 福田, 大受, Salim, Hotimah Masdan, 八木, 秀介, 楠瀬, 賢也, 山田, 博胤, 添木, 武, 佐田, 政隆Japan Atherosclerosis Society2020-11-01Journal of Atherosclerosis and Thrombosis27 11p.1141-1151
インターネットで読める全国の図書館
  • 件名SGLT2 inhibitor Canagliflozin Atherosclerosis...

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.

SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.
デジタル博士論文
富田, 一聖, TOMITA, IsseiElsevier B.V.2020Cell metabolism32 3p.404-419.e6
インターネットで読める全国の図書館
  • 要約等SGLT2 inhibitors offer strong renoprotection ...
  • 件名...is ketone body SGLT2 inhibitor lipolysis ketolysis mTORC1 nu...

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).
デジタル博士論文
Nakajima, Hiroki, Okada, Sadanori, Mohri, Takako, Kanda, Eiichiro, Inaba, Naoyuki, Hirasawa, Yoko, Seino, Hiroaki, Kuroda, Hisamoto, Hiyoshi, Toru, Niiya, Tetsuji, Ishii, HitoshiBioMed Central2018-03-01Diabetology and metabolic syndrome10p.Article No.11-
インターネットで読める全国の図書館
  • 件名...s 2 inhibitors SGLT2 inhibitors Dapagliflozin Treatment sati...
  • 一般注記...agliflozin, an SGLT2 inhibitor, improves treatment satisfact...

心不全の病態と治療

心不全の病態と治療
デジタル文書・図像類
柳澤, 輝行2022-03-18p.1-44
全国の図書館
  • 件名...ndil diuretics SGLT2 inhibitor cardiotonic agents digitalis ...

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 Inhibitor use

Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 Inhibitor use
デジタル博士論文
後藤, 由佳
インターネットで読める全国の図書館
  • 件名SGLT2 inhibitor diabetes mellitus glucose flu...

非アルコール性脂肪性肝炎(NASH)メダカモデルの肝臓および血管系に対する新規選択的PPARαモジュレーター、スタチン、ナトリウム-グルコース共輸送体2阻害剤の単剤および併用療法の効果

非アルコール性脂肪性肝炎(NASH)メダカモデルの肝臓および血管系に対する新規選択的PPARαモジュレーター、スタチン、ナトリウム-グルコース共輸送体2阻害剤の単剤および併用療法の効果
デジタル博士論文
木村, 淳史
インターネットで読める全国の図書館
  • 件名NASH fli::GFP transgenic medaka SPPARMα statin SGLT2 inhibitor

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
デジタル博士論文
吉本, 卓生
インターネットで読める全国の図書館
  • 要約等...2 diabetes. An SGLT2 inhibitor (canagliflozin......Treatment with SGLT2 inhibitors significantly......inistration of SGLT2 inhibitors. However, the......treatment with SGLT2 inhibitors does not activate the intrar...
  • 件名SGLT2 inhibitor blood pressure type 2 diabete...

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in an animal model of obese type 2 diabetes

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in an animal model of obese type 2 diabetes
デジタル博士論文
原, 健人
インターネットで読める全国の図書館
  • 件名Fat oxidation Metabolic inflexibility Obesity SGLT2 inhibitor Type 2 diabetes mellitus

糖尿病発症ApoE欠損マウスを用いたGLP-1受容体作動薬及びSGLT2阻害薬併用の動脈硬化性病変と腎病変への効果の解析

糖尿病発症ApoE欠損マウスを用いたGLP-1受容体作動薬及びSGLT2阻害薬併用の動脈硬化性病変と腎病変への効果の解析
デジタル博士論文
田久保,正洋p.1-
インターネットで読める全国の図書館
  • 件名...eptor agonists SGLT2 inhibitors
  • 並列タイトル等（連結）...therapy with a SGLT2 inhibitor and a GLP-1 receptor agonist ...
  • 並列タイトル等...therapy with a SGLT2 inhibitor and a GLP-1 receptor agonist ...

検索結果は以上です。

RSS